Related Experiment Video
Updated: Aug 5, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions)
Aude Espinasse1, Olga Solovyeva1, Munyaradzi Dimairo2
1Clinical Trial and Statistical Unit, Institute of Cancer Research Sutton, London, UK.
New guidelines, SPIRIT-DEFINE and CONSORT-DEFINE, will improve early phase dose-finding (EPDF) trial reporting. These extensions address current gaps to enhance transparency and reproducibility in clinical research.
Area of Science:
- Clinical Trials
- Pharmaceutical Development
- Medical Research Methodology
Background:
- Early phase dose-finding (EPDF) studies are crucial for advancing new treatments.
- Existing guidelines like SPIRIT 2013 and CONSORT 2010 do not fully address EPDF trial specifics.
- Gaps in EPDF trial reporting impact the progression of potential therapies.
Purpose of the Study:
- To enhance transparency, completeness, reproducibility, and interpretation of EPDF trial protocols and reports.
- To develop extensions to SPIRIT and CONSORT guidelines tailored for EPDF studies.
- To build upon existing SPIRIT 2013 and CONSORT 2010 frameworks.
Main Methods:
- Methodological review of published EPDF trials to identify reporting deficiencies.
- Enrichment of draft checklists through literature review, real-world data analysis, and expert consultation.
- Modified Delphi process and international consensus meeting to finalize guidance items.
Main Results:
- Development of SPIRIT-DEFINE and CONSORT-DEFINE is underway, with registration on the EQUATOR Network.
- Candidate items for the new guidelines are being generated and refined.
- International expert and stakeholder engagement is integral to the development process.
Conclusions:
- SPIRIT-DEFINE and CONSORT-DEFINE aim to significantly improve the quality of EPDF trial documentation.
- These extensions will support more robust evaluation and progression of novel therapeutic interventions.
- Enhanced reporting will ultimately benefit patient safety and treatment efficacy.
More Related Videos
08:22Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...